Clinical aspects and treatment of juvenile Graves' disease

Experimental and Clinical Endocrinology and Diabetes

Volumn 105, Issue SUPPL. 4, 1997, Pages 55-57

  Perrild, H ^a,b   Lavard, L ^a   Brock Jacobsen, B ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b BISPEBJERG HOSPITAL   (Denmark)

Author keywords

HLAtype; Juvenile thyrotoxicosis; Medical therapy; Radioiodine; Surgery; Thyrotoxicosis in childhood

Indexed keywords

HLA DR ANTIGEN;

CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; GOITER; GRAVES DISEASE; HUMAN; PRIORITY JOURNAL; THYROTOXICOSIS;

EID: 0030832845     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211934     Document Type: Conference Paper

References (14)

1. Feldt-Rasmussen U, Schleusener H, Carayon P. meta-analysis evaluation of the impact of thyrotropin receptor antibodies on longterm remission after medical therapy of Graves' disease J Clin Endocrinol Metab 78: 98-102, 1994
2. Foley TP, White C, New A. Juvenile Graves' disease. Usefulness and limitations of thyrotropin receptor antibody determinations. J Pediatr 110: 378-86, 1987
3. Glaser NS, Styne DM. Predictors of early remission of hyperthyroidism in children. J Clin Endocrinol Metab 82: 1719-1726, 1997
4. Hashizume K, Ichikawa K, Sakurai A, Suzuki S, Takeda T et al. Administration of thyroxine in treated Graves' disease. Effect on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyrodism. N Eng J Med 324: 947-953, 1991
5. Lavard L, Perrild H, Ranløv I, Andersen O, Brock-Jacobsen B. Incidence of Juvenile thyrotoxicosis in Denmark 1982-88. Eur J Endocrinol 130: 565-568, 1994
6. Lavard L, Perrild H, Brock-Jacobsen B, Høyer-Madsen M, Vitti P. Anti-TPO, Tg and TSHR-antibodies in juvenile Graves' disease. J Endocrinol Invest, ETA, Vienna, 1994a
7. Lavard L, Madsen HO, Perrild H, Brock-Jacobsen B, Svejgaard A. HLA class II association in juvenile Graves'. Indication of a strong protective role of the DRB1*0701, DQA1*0201 haplotype. Tissue antigen in press 1997
8. Lavard L, Sehested A, Brock-Jacobsen B, Muller J, Perrild H, Parma J Vassart G. Longterm follow up of an infant with thyrotoxicosis due to a germline mutation of TSHR gene (met453Thr), ESPE, Stockholm, 1997
9. Lippe BM, Landaw EM, Kaplan SA. Hyperthyroidism in children treated with londterm medical therapy. J Clin Endocrinol Metab 64: 1241-1245, 1987
10. Laurberg P, Buchholtz Hansen PE, Iversen E, Eskjaer Jensen S, Weeke J. Goitre size and outcome of medical treatment of Graves' disease. Acta Endocrinol 111: 39-43, 1986
11. Laurberg P, Pedersen KM, Vestergaard H, Sigurdsson G. High incidence of multinoduar toxic goitre in the elderly population in a ow iodine intake area vs. High incidence of Graves' disease in the young in a high iodine intake area: comparative surveys of tyrotoxicosis epidemiology in East-Jutland Denmark and Iceland. J Int Medicine 229: 415-420, 1991
12. McIver B, Rae P, Beckett G, Wilkinson E, Gold A, Toft A. Lack of effect of thyroxine in patients with Graves' hyperthyroidism who are treated with an antithyroid drug. N Eng J Med 334: 220-224, 1996
13. Perrild H, Gruters-Kieslich A, Feldt-Rasmussen U, Grant D, Martino E, Kayser L, DeLange F. Diagnosis and treatment of thyrotoxicosis in childhood. A European questionnaire study. European J Endocrinol 131: 467-473, 1994
14. Safa M, Schumacher OP, Rodrigeues-Antunez A. Longterm follow up results in children and adolescent treated with radioiodine for hyperthyroidism N Eng J Med 292: 167-170, 1975